宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688247 宣泰医药

已收盘 05-20 15:00:00

{"stockData":{"symbol":"688247","market":"SH","secType":"STK","nameCN":"宣泰医药","latestPrice":9.54,"timestamp":1716188400000,"preClose":9.4,"halted":0,"volume":1727909,"delay":0,"floatShares":140000000,"shares":453000000,"eps":0.1683,"marketStatus":"已收盘","marketStatusCode":5,"change":0.14,"latestTime":"05-20 15:00:00","open":9.48,"high":9.61,"low":9.32,"amount":16395000,"amplitude":0.0309,"askPrice":9.55,"askSize":1161,"bidPrice":9.54,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.1683,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716255000000},"adr":0,"adjPreClose":9.4,"symbolType":"stock_kcb","openAndCloseTimeList":[[1716168600000,1716175800000],[1716181200000,1716188400000]],"highLimit":10.34,"lowLimit":8.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":453340000,"pbRate":3.6,"roa":"--","roe":"1.88%","epsLYR":0.13,"committee":-0.769766,"marketValue":4325000000,"floatMarketCap":1336000000,"peRate":56.684491,"changeRate":0.0149,"turnoverRate":0.0123,"status":0,"afterMarket":{"amount":0,"volume":0,"close":9.54,"buyVolume":0,"sellVolume":0,"time":1716190439505,"indexStatus":"已收盘 05-20 15:30:00","preClose":9.4}},"requestUrl":"/m/hq/s/688247","defaultTab":"news","newsList":[{"id":"2436233114","title":"熊去氧胆酸概念盘中拉升，宣泰医药涨2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436233114","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436233114?lang=zh_cn&edition=full","pubTime":"2024-05-20 09:55","pubTimestamp":1716170128,"startTime":"0","endTime":"0","summary":"05月20日，熊去氧胆酸概念盘中拉升，截至09点55分，熊去氧胆酸概念整体指数上涨0.52%，报996.100点。从个股上来看，该概念的成分股中，宣泰医药涨2.13%，科伦药业、广生堂、吉贝尔涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-675.52万，其中上海医药受到资金热捧，主力净流入352.17万；拉长时间线来看，该板块近20日主力资金净流入-22.36亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052009552887e889b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052009552887e889b8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436958950","title":"北向资金5月16日净卖出宣泰医药13.16万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2436958950","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436958950?lang=zh_cn&edition=full","pubTime":"2024-05-17 09:30","pubTimestamp":1715909437,"startTime":"0","endTime":"0","summary":"5月16日，北向资金减持宣泰医药13.16万股连续3日减持。截止当日收盘，沪股通共持有宣泰医药36.83万股，占流通股0.26%。沪股通减持金额前五个股分别为伊利股份、国电南瑞、中国石化、恒瑞医药、中国联通。宣泰医药近5个交易日下跌5.44%，沪股通累计减持1.87万股；近20个交易日上涨20.69%，沪股通累计增持8.00万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170935048b10c024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170935048b10c024&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434518072","title":"CRO概念盘中跳水，宣泰医药跌0.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434518072","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434518072?lang=zh_cn&edition=full","pubTime":"2024-05-10 10:09","pubTimestamp":1715306953,"startTime":"0","endTime":"0","summary":"05月10日，CRO概念盘中跳水，截至10点09分，CRO概念整体指数下跌1.01%，报405.530点。从个股上来看，该概念的成分股中，宣泰医药跌0.30%，诚达药业、普蕊斯跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-4.10亿，其中药石科技受到资金热捧，主力净流入1283.51万；拉长时间线来看，该板块近20日主力资金净流入-50.25亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510100913861ec4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510100913861ec4a8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434907131","title":"熊去氧胆酸概念盘中拉升，宣泰医药涨1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434907131","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434907131?lang=zh_cn&edition=full","pubTime":"2024-05-10 09:41","pubTimestamp":1715305310,"startTime":"0","endTime":"0","summary":"05月10日，熊去氧胆酸概念盘中拉升，截至09点41分，熊去氧胆酸概念整体指数上涨0.57%，报1045.930点。从个股上来看，该概念的成分股中，宣泰医药涨1.91%，赛托生物、千红制药、上海医药涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-7671.32万，其中科伦药业受到资金热捧，主力净流入688.43万；拉长时间线来看，该板块近20日主力资金净流入-12.93亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100941507926e443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100941507926e443&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433715484","title":"宣泰医药05月08日主力资金流入730万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2433715484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433715484?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:19","pubTimestamp":1715152774,"startTime":"0","endTime":"0","summary":"05月08日, 宣泰医药股价涨1.61%，报收10.08元，成交金额4840万元，换手率3.41%，振幅4.44%，量比1.14。宣泰医药今日主力资金净流入730万元，连续3日净流入，上一交易日主力净流入206万元，今日环比增加254.37%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为25.00%，平均涨幅为1.18%。该股近5个交易日上涨15.46%，主力资金累计净流入1227万元；近20日主力资金累计净流入1292万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081540228ae7dd48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405081540228ae7dd48&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433757291","title":"宣泰医药获融资买入0.11亿元，近三日累计买入0.21亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433757291","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433757291?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:25","pubTimestamp":1715127915,"startTime":"0","endTime":"0","summary":"5月7日，沪深两融数据显示，宣泰医药获融资买入额0.11亿元，居两市第761位，当日融资偿还额0.03亿元，净买入779.73万元。最近三个交易日，30日-7日，宣泰医药分别获融资买入0.04亿元、0.07亿元、0.11亿元。融券方面，当日融券卖出1.16万股，净卖出0.72万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050808261987de1d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050808261987de1d25&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433486266","title":"宣泰医药：累计回购约419万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433486266","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2433486266?lang=zh_cn&edition=full","pubTime":"2024-05-05 17:11","pubTimestamp":1714900260,"startTime":"0","endTime":"0","summary":"宣泰医药（SH 688247，收盘价：9.48元）5月5日晚间发布公告称，截至2024年4月30日，公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份约419万股，占公司总股本约4.53亿股的比例为0.92%，购买的最高价为8.98元/股，最低价为8元/股，支付的资金总额为人民币约3501万元。2023年1至12月份，宣泰医药的营业收入构成为：医药制造业占比99.84%。截至发稿，宣泰医药市值为43亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050517164887d44190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050517164887d44190&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433486265","title":"宣泰医药：已累计回购股份418.61万股，占总股本比例0.92%，累计已回购金额3500.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433486265","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433486265?lang=zh_cn&edition=full","pubTime":"2024-05-05 16:59","pubTimestamp":1714899573,"startTime":"0","endTime":"0","summary":"宣泰医药 公告，公司于2024年4月通过上海证券交易所交易系统以集中竞价交易方式回购股份32.6万股，占公司总股本4.53亿股的比例为0.07%，购买的最高价为8.30元/股，最低价为8.20元/股，支付的资金总额为人民币269.09万元。截至2024年4月30日，公司已累计回购股份418.61万股，占公司总股本的比例为0.92%，购买的最高价为8.98元/股，最低价为8.00元/股，支付的资金总额为人民币3500.56万元。本次回购股份符合法律法规的规定及公司回购股份方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405051710228b75ec0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405051710228b75ec0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433714488","title":"宣泰医药：参加2023年度科创板制药专场集体业绩说明会暨2024年第一季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2433714488","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433714488?lang=zh_cn&edition=full","pubTime":"2024-05-05 16:04","pubTimestamp":1714896259,"startTime":"0","endTime":"0","summary":"宣泰医药公告称，公司已于2024年4月30日发布公司2023年年度报告及2024年第一季度报告，为便于广大投资者更全面深入地了解公司2023年度及2024年第一季度的经营成果、财务状况，公司计划于2024年5月20日下午15:00-17:00参加由上海证券交易所主办的2023年度科创板制药专场集体业绩说明会，就投资者关心的问题进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050516042787d40689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050516042787d40689&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431338337","title":"宣泰医药2023年营收3亿净利6107.41万 总经理郭明洁薪酬160.78万","url":"https://stock-news.laohu8.com/highlight/detail?id=2431338337","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2431338337?lang=zh_cn&edition=full","pubTime":"2024-04-30 11:14","pubTimestamp":1714446853,"startTime":"0","endTime":"0","summary":"挖贝网4月29日，宣泰医药 近日发布2023年年度报告，报告期内公司实现营业收入299,871,288.42元，同比增长21.13%；归属于上市公司股东的净利润61,074,068.07元，同比下滑34.28%。报告期内经营活动产生的现金流量净额为12,958,036.70元，归属于上市公司股东的净资产1,210,258,935.42元。公告显示，报告期内董事、监事、高级管理人员报酬合计974.11万元。公司2023年度利润分配方案已经公司第二届董事会第九次会议审议通过，尚需提请公司2023年年度股东大会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043011310187c1ef72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043011310187c1ef72&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431751386","title":"宣泰医药创3月新高 年内产品销售收入大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2431751386","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2431751386?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:20","pubTimestamp":1714443653,"startTime":"0","endTime":"0","summary":"04月30日，宣泰医药股价大幅上涨，截至10点20分，宣泰医药上涨5.00%，报9.45元/股，创近3月新高，成交2424万元，换手率1.87%。消息解读宣泰医药在2023年实现营业收入2.99亿元，同比增长21.13%，归母净利润为6107.41万元。同年，宣泰医药商业化进程加速，年内产品销售收入同比增长148.08%。2024年第一季度，宣泰医药营收约1.11亿元，同比增加162.65%；归属于上市公司股东的净利润约2290万元，同比增加196.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430102354792551cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430102354792551cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431818144","title":"图解宣泰医药年报：第四季度单季净利润同比减34.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431818144","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431818144?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:40","pubTimestamp":1714408805,"startTime":"0","endTime":"0","summary":"证券之星消息，宣泰医药2023年年报显示，公司主营收入3.0亿元，同比上升21.13%；归母净利润6107.41万元，同比下降34.28%；扣非净利润4747.37万元，同比下降36.01%；其中2023年第四季度，公司单季度主营收入8650.69万元，同比上升42.61%；单季度归母净利润1700.14万元，同比下降34.18%；单季度扣非净利润1057.3万元，同比上升23.6%；负债率11.12%，投资收益1136.91万元，财务费用-724.06万元，毛利率55.89%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000455987c03985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000455987c03985&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431830870","title":"宣泰医药：拟聘任上会会计师事务所为2024年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2431830870","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431830870?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:17","pubTimestamp":1714389473,"startTime":"0","endTime":"0","summary":"4月29日消息， 宣泰医药 公告称，公司拟聘任上会会计师事务所 为2024年度审计机构。上会会计师事务所的基本信息如下：首席合伙人为张晓荣，主要经营场所位于上海市静安区威海路755号25层，成立日期为2013年12月27日。上会2023年度经审计的收入总额为7.06亿元，审计业务收入为4.64亿元，证券业务收入为2.11亿元。本次聘任会计师事务所事项尚需提交公司股东大会审议，并自公司股东大会审议通过之日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291922228b61cd41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291922228b61cd41&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431935986","title":"以更大力度深化国企改革 集聚优势资源发展新质生产力","url":"https://stock-news.laohu8.com/highlight/detail?id=2431935986","media":"央视网","top":-1,"share":"https://www.laohu8.com/m/news/2431935986?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:12","pubTimestamp":1714389120,"startTime":"0","endTime":"0","summary":"4月28日，国务院国资委在湖南株洲召开国有企业改革深化提升行动现场推进会。有关负责人表示，要以更大力度的改革，推动加快培育和发展新质生产力。截至今年一季度末，各中央企业在发展战新产业和未来产业，提升自主创新能力等方面，呈现多点突破态势。王宏志还表示，要坚持深化国企改革，通过盘活低效无效资产、闲置土地等方式，集聚优势资源发展战略性新兴产业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291915277a57149c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291915277a57149c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431383923","title":"宣泰医药：2024年第一季度净利润约2290万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431383923","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431383923?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:25","pubTimestamp":1714386346,"startTime":"0","endTime":"0","summary":"宣泰医药（SH 688247，收盘价：9元）4月29日晚间发布一季度业绩公告称，2024年第一季度营收约1.11亿元，同比增加162.65%；归属于上市公司股东的净利润约2290万元，同比增加196.71%。宣泰医药的董事长是叶峻，男，52岁，学历背景为硕士；总经理是郭明洁，男，51岁，学历背景为硕士。截至发稿，宣泰医药市值为41亿元。文章来源：每日经济新闻原标题：宣泰医药：2024年第一季度净利润约2290万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291839218b619d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291839218b619d54&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431833077","title":"宣泰医药：宣泰医药坚持以可持续发展理念促进公司高质量发展，将可持续发展理念融入公司战略及运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2431833077","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431833077?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:01","pubTimestamp":1714384899,"startTime":"0","endTime":"0","summary":"宣泰医药坚持以可持续发展理念促进公司高质量发展，将可持续发展理念融入公司战略及运营。未来，公司将继续以长期主义践行高质量可持续发展，将可持续发展理念与公司发展战略、业务、文化全面、深度融合，为经济、环境、社会、人类福祉创造价值。公司及董事会具有完善的风险控制体系制度。2024年第一季度，公司产品美沙拉秦肠溶缓释片获得国家药品监督管理局批准上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042918040787beb83f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042918040787beb83f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431740887","title":"宣泰医药(688247.SH)发布一季度业绩，净利润2289.59万元 同比增加196.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431740887","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431740887?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:52","pubTimestamp":1714384338,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宣泰医药(688247.SH)发布2024年一季度报告，报告期内公司实现营业收入1.11亿元，同比增加162.65%;归属于上市公司股东的净利润2289.59万元，同比增加196.71%;归属于上市公司股东的扣除非经常性损益的净利润2174.82万元，同比增加304.66%;基本每股收益0.05元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114450.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431887420","title":"宣泰医药(688247.SH)发布2023年度业绩，净利润6107.41万元 同比减少34.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431887420","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431887420?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:50","pubTimestamp":1714384220,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宣泰医药(688247.SH)发布2023年度业绩报告，报告期内公司实现营业收入3亿元，同比增加21.13%;归属于上市公司股东的净利润6107.41万元，同比减少34.28%;归属于上市公司股东的扣除非经常性损益的净利润4747.37万元，同比减少36.01%;基本每股收益0.13元，公司拟向全体股东每10股派发现金红利0.41元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114442.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431882287","title":"图解宣泰医药一季报：第一季度单季净利润同比增196.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431882287","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431882287?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:40","pubTimestamp":1714383656,"startTime":"0","endTime":"0","summary":"证券之星消息，宣泰医药2024年一季报显示，公司主营收入1.11亿元，同比上升162.65%；归母净利润2289.59万元，同比上升196.71%；扣非净利润2174.82万元，同比上升304.66%；负债率11.27%，投资收益100.68万元，财务费用-128.53万元，毛利率45.45%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900022895.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-08-25","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路780号7层709室","stockEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":0.148},{"period":"3month","weight":0.197},{"period":"6month","weight":-0.203},{"period":"1year","weight":-0.3152},{"period":"ytd","weight":-0.1311}],"companyName":"上海宣泰医药科技股份有限公司","boardCode":"AI0027","perCapita":"19148股","boardName":"医药制造业","registeredCapital":"45334万元","compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.085},{"period":"6month","weight":0.0419},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.066}],"survey":"　　上海宣泰医药科技股份有限公司的主营业务是高端仿制药的研发、生产和销售以及CRO服务。公司的主要产品是高端仿制药、CRO服务。公司先后获得“上海市专利工作试点企业”、“上海市‘专精特新’中小企业”、“第四届上海知识产权创新奖专利二等奖”等荣誉。","serverTime":1716249745221,"listedPrice":9.37,"stockholders":"7314人(较上一季度减少9.47%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宣泰医药,688247,宣泰医药股票,宣泰医药股票老虎,宣泰医药股票老虎国际,宣泰医药行情,宣泰医药股票行情,宣泰医药股价,宣泰医药股市,宣泰医药股票价格,宣泰医药股票交易,宣泰医药股票购买,宣泰医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}